Viekira pak and Syncope aggravated - a phase IV clinical study of FDA data
Summary:
Syncope aggravated is reported as a side effect among people who take Viekira pak (dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Truvada, and have Hepatitis c.
The phase IV clinical study analyzes which people have Syncope aggravated when taking Viekira pak. It is created by eHealthMe based on reports of 10,520 people who have side effects when taking Viekira pak from the FDA, and is updated regularly.
What is Viekira pak?
Viekira pak has active ingredients of dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir. eHealthMe is studying from 10,521 Viekira pak users. Check the latest studies of Viekira pak.
What is Syncope aggravated?
Syncope aggravated (a loss of consciousness with an inability to maintain postural tone) is found to be associated with 1,690 drugs and 590 conditions by eHealthMe. Check the latest studies of Syncope aggravated.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
10,520 people reported to have side effects when taking Viekira pak.
Among them, 42 people (0.4%) have Syncope aggravated.

Among these 42 people:
How long have people been on Viekira pak when they have Syncope aggravated? *
- < 1 month: 40 %
- 1 - 6 months: 60 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Syncope aggravated when taking Viekira pak? *
- female: 46.15 %
- male: 53.85 %
What is the age of people who have Syncope aggravated when taking Viekira pak? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 6.9 %
- 40-49: 20.69 %
- 50-59: 31.03 %
- 60+: 41.38 %
What are other drugs people take besides Viekira pak? *
- Metformin: 3 people, 7.14%
- Truvada: 3 people, 7.14%
- Norco: 2 people, 4.76%
- Risperdal: 2 people, 4.76%
- Xanax: 2 people, 4.76%
- Darunavir: 2 people, 4.76%
- Celexa: 2 people, 4.76%
- Januvia: 2 people, 4.76%
- Ribasphere: 2 people, 4.76%
- Vitamin D: 2 people, 4.76%
What are other side effects people have besides Syncope aggravated? *
- Dizziness: 9 people, 21.43%
- Weakness: 6 people, 14.29%
- Nausea (feeling of having an urge to vomit): 6 people, 14.29%
- Headache (pain in head): 5 people, 11.90%
- Nausea And Vomiting: 4 people, 9.52%
- Fatigue (feeling of tiredness): 4 people, 9.52%
- Haemoglobin Decreased: 3 people, 7.14%
- Blood Glucose Decreased: 3 people, 7.14%
- Hypotension (abnormally low blood pressure): 3 people, 7.14%
- Road Traffic Accident: 3 people, 7.14%
What are the existing conditions these people have? *
- Hepatitis C: 33 people, 78.57%
- Insomnia (sleeplessness): 2 people, 4.76%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.76%
- Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 2 people, 4.76%
- Hiv Infection: 2 people, 4.76%
- Thrombocytopenia (decrease of platelets in blood): 1 person, 2.38%
- High Blood Cholesterol: 1 person, 2.38%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.38%
- Diabetes: 1 person, 2.38%
- Gastritis (inflammation of stomach): 1 person, 2.38%
* Approximation only. Some reports may have incomplete information.
Do you take Viekira pak and have Syncope aggravated?
- Check whether Syncope aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Viekira pak:
- Viekira pak (10,521 reports)
Syncope aggravated treatments and more:
- Syncope aggravated (17 reports)
How severe was Syncope aggravated and when was it recovered:
Expand to all the drugs that have ingredients of dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Viekira pak:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Syncope aggravated:
- Syncope aggravated (1,691 drugs)
Browse all the conditions that are associated with Syncope aggravated:
- Syncope aggravated (590 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir (the active ingredients of Viekira pak) and Viekira pak (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aloxi cause Paronychia? - 3 seconds ago
- Could Onpattro cause Memory Loss? - 9 seconds ago
- Could Remodulin cause Gingival Bleeding? - 17 seconds ago
- Could Ranitidine Hydrochloride cause Allergy To Chemicals? - 19 seconds ago
- Could Albuterol cause Nipple Pain? - 31 seconds ago
- Could Rabeprazole cause Bundle Branch Block Right? - 40 seconds ago
- Could Norvir cause Hospitalisation? - 41 seconds ago
- Could Rabeprazole Sodium cause Asthma? - 42 seconds ago
- Could Yervoy cause Weight Loss? - 43 seconds ago
- Could Rabeprazole cause Joint Destruction? - 44 seconds ago